Cases & Controversies in Colon Cancer


Tuesday, May 3, 9:00 - 9:45 am

CME Credit Hours: 0.75

This symposium focuses on cutting edge and controversial topics in the management of colon cancer. 

Objectives

At the conclusion of this session, participants should be able to:
  1. Describe current techniques to identify which patients with stage II colon cancer would likely benefit from adjuvant chemotherapy.
  2. Compare relative benefits and risks of segmental and endoscopic resection for malignant colon polyps
  3. Identify the benefits of complete mesocolic excision for colon malignancy

Agenda

Co-Directors:    
Srinivas Joga Ivatury, MD, Lebanon, NH

Virginia Shaffer, MD, Atlanta, GA

Social Media
Moderator:       
Paul Johnson, MD, Winter Park, FL 

 
9:00 am               
Introduction
Srinivas Joga Ivatury, MD, Lebanon, NH
Virginia Shaffer, MD, Atlanta, GA
 
9:05 am               
Cases:
Tailoring Adjuvant Therapy in High-Risk Stage II Colon Cancer: Use of New Diagnostic Techniques Including ctDNA
Malignant Polyps – How Do You Decide? Segmental versus Endoscopic Resection
Complete Mesocolic Excision and D3 Lymphadenectomy – Is there a Role in Colon Cancer?
               
Panel:
Marylise Boutros, MD, Montreal, QC, Canada
Evie Carchman, MD, Madison, WI
David Rosen, MD, Cleveland, OH
April Roslani, MD, Kulal Lumpur, Malaysia
 
9:35 am               
Panel Discussion and Questions and Answers
 
9:45 am               
Adjourn